Dermatology Drug Developer Can Tap $3M Of Ch. 11 Loan
Bankrupt drug developer Timber Pharmaceuticals Inc. received interim approval Tuesday to access a portion of its $13.9 million Chapter 11 financing package after adding protections for unsecured creditors at the request...To view the full article, register now.
Already a subscriber? Click here to view full article